These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 26855409

  • 1. Meningococcal Conjugate and Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccination Among HIV-infected Youth.
    Setse RW, Siberry GK, Moss WJ, Wheeling J, Bohannon BA, Dominguez KL, LEGACY Consortium.
    Pediatr Infect Dis J; 2016 May; 35(5):e152-7. PubMed ID: 26855409
    [Abstract] [Full Text] [Related]

  • 2. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases.
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [Abstract] [Full Text] [Related]

  • 3. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
    Tashani M, Alfelali M, Barasheed O, Alqahtani AS, Heron L, Wong M, Rashid H, Findlow H, Borrow R, Booy R.
    Vaccine; 2018 Jul 05; 36(29):4375-4382. PubMed ID: 29880243
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunogenicity and reactogenicity of co-administered tetanus-diphtheria-acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration.
    Weston WM, Friedland LR, Wu X, Howe B.
    Vaccine; 2011 Jan 29; 29(5):1017-22. PubMed ID: 21134450
    [Abstract] [Full Text] [Related]

  • 8. Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade.
    Kharbanda EO, Stockwell MS, Colgrove J, Natarajan K, Rickert VI.
    Am J Public Health; 2010 Sep 29; 100(9):1635-40. PubMed ID: 20634463
    [Abstract] [Full Text] [Related]

  • 9. Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial.
    Tashani M, Alfelali M, Barasheed O, Alqahtani AS, Heron L, Wong M, Rashid H, Booy R.
    Vaccine; 2016 Nov 21; 34(48):5929-5937. PubMed ID: 27780630
    [Abstract] [Full Text] [Related]

  • 10. Vaccination coverage among adolescents aged 13-17 years - United States, 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Oct 10; 57(40):1100-3. PubMed ID: 18846032
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM, Friedland LR, Wu X, Howe B.
    Vaccine; 2012 Feb 21; 30(9):1721-8. PubMed ID: 22212127
    [Abstract] [Full Text] [Related]

  • 13. Adolescent vaccine co-administration and coverage in New York City: 2007-2013.
    Sull M, Eavey J, Papadouka V, Mandell R, Hansen MA, Zucker JR.
    Pediatrics; 2014 Dec 21; 134(6):e1576-83. PubMed ID: 25384490
    [Abstract] [Full Text] [Related]

  • 14. A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan.
    Gowda C, Dong S, Potter RC, Dombkowski KJ, Dempsey AF.
    J Adolesc Health; 2013 Oct 21; 53(4):498-505. PubMed ID: 24054080
    [Abstract] [Full Text] [Related]

  • 15. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.
    Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV, Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices, Healthcare Infection Control Practices Advisory Committee.
    MMWR Recomm Rep; 2006 Dec 15; 55(RR-17):1-37. PubMed ID: 17167397
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States.
    Havers FP, Cho BH, Walker JW, Hariri S.
    Vaccine; 2020 Jan 10; 38(2):380-387. PubMed ID: 31676198
    [Abstract] [Full Text] [Related]

  • 19. Missed opportunities for adolescent vaccination, 2006-2011.
    Wong CA, Taylor JA, Wright JA, Opel DJ, Katzenellenbogen RA.
    J Adolesc Health; 2013 Oct 10; 53(4):492-7. PubMed ID: 23809613
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.